TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD.

Stokes A, Wakano C, Koblan-Huberson M, Adra CN, Fleig A, Turner H. TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD. Cell Signal. 2006 Oct; 18(10):1584-94.

View in: PubMed

authors with profiles

Alexander J. Stokes, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support